Clinical Trial

Prophylactic Antibiotic Treatment in Hemodialysis

Study acronym: PANTHEM
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the efficacy of prophylactic antibiotic treatment on blood stream infections and severe culture negative infections, in patients on newly started hemodialysis(HD), with a central venous catheter as vascular access.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-02-09; most recent amendment 2024-01-28.
Status change: Not Yet Recruiting → Recruiting 2022-05-20
Trial Details
NCT Number NCT05248620
Lead Sponsor Zealand University Hospital
Conditions Hemodialysis
Enrollment 800 participants
Start Date 2022-02-14
Primary Completion 2028-10 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2024-01-30